NF-κB signaling proteins as therapeutic targets for inflammatory bowel diseases

Inflammatory Bowel Diseases

Volumn 6, Issue 3, 2000, Pages 206-213

  Jobin, Christian ^a,b   Balfour Sartor, R ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF NORTH CAROLINA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN;

ENTERITIS; GENETIC TRANSCRIPTION; HUMAN; PATHOPHYSIOLOGY; REVIEW; SIGNAL TRANSDUCTION;

HUMANS; INFLAMMATORY BOWEL DISEASES; NF-KAPPA B; SIGNAL TRANSDUCTION; TRANSCRIPTION, GENETIC;

EID: 0034243239     PISSN: 10780998     EISSN: None     Source Type: Journal    
DOI: 10.1097/00054725-200008000-00007     Document Type: Article

References (5)

1. Elson CO, Sartor RB, Tennyson GS, et al. Experimental models of inflammatory bowel disease. Gastroenterology 1995;109:1344-67.
2. Sartor RB. Pathogenesis and immune mechanism of chronic inflammatory bowel diseases. Am J Gastroenterol 1997;92:5S-11S.
3. Barnes PJ, Karin M. Nuclear factor-κB, a pivotal transcription factor in chronic inflammatory diseases. N Engl J Med 1997;336:1066-71.
4. Baeuerle PA, Henkle T. Function and activation of NF-κB in the immune system. Ann Rev Immunol 1994;12:141-79.
5. Chen FE, Ghosh G. Regulation of DNA binding by Rel/NF-κB transcription factors: structural views. Oncogene 1999;18:6845-52.